UHS · Universal Health Services Inc
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Jul 28, 2026TL;DR. UHS reported Q2 adjusted EPS of $5.98 (+12% YoY) and adjusted EBITDA less NCI of $678 million (+5% YoY), but lowered full-year 2026 adjusted EBITDA guidance by approximately $50 million at the midpoint to a range of $2.61–$2.72 billion due to higher professional/general liability reserves, elevated losses at the San Antonio behavioral facility and Cedar Hill, and lower volume assumptions, partially offset by an unbudgeted $100 million Florida DPP benefit.
- + Q2 included an unbudgeted $100 million favorable Florida Medicaid DPP benefit that was not in original guidance.
- + Added 177 licensed beds (2.5% increase to same-facility acute care bed capacity) including opening the Allen B. Miller Medical Center.
- + Share repurchases accelerated to $320 million in Q2 from $127 million in Q1, with $978 million remaining authorization.
- + Pending Talkspace acquisition expected to close mid-August 2026, creating a national end-to-end behavioral health continuum.
- − UHS lowered 2026 adjusted EBITDA less NCI guidance by about $50 million at the midpoint to $2.61–$2.72 billion (1.9% decrease at midpoint).
- − Increased professional and general liability reserves added $28 million pre-tax in Q2 and ~$50 million for full-year 2026.
- − San Antonio behavioral hospital lost certification, incurring $10 million pre-tax loss in Q2 and expected $5–10 million quarterly losses through year-end.
- − Cedar Hill (Washington D.C.) de novo ramping slower than expected; tailwind reduced from $50 million to $20 million, now expected to reach break-even only in Q4.
- − Lowered full-year same-facility volume guidance: acute care admissions to 1.5–2.5% and behavioral health patient days to 1.0–2.0%.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Admissions (All) | 88,649 | Three Months Ended June 30, 2026 filing | — |
| Admissions (Same Facility Basis) non-GAAP | 88,562 | Three Months Ended June 30, 2026 filing | — |
| Average available beds (All) | 7,262 | Three Months Ended June 30, 2026 filing | — |
| Average available beds (Same Facility Basis) non-GAAP | 7,158 | Three Months Ended June 30, 2026 filing | — |
| Average daily census (All) | 4,615.4 | Three Months Ended June 30, 2026 filing | — |
| Average daily census (Same Facility Basis) non-GAAP | 4,612.2 | Three Months Ended June 30, 2026 filing | — |
| Average licensed beds (All) | 7,434 | Three Months Ended June 30, 2026 filing | — |
| Average licensed beds (Same Facility Basis) non-GAAP | 7,330 | Three Months Ended June 30, 2026 filing | — |
| Length of stay (All) | 4.7 | Three Months Ended June 30, 2026 filing | — |
| Occupancy-available beds (All) | 63.6% | Three Months Ended June 30, 2026 filing | — |
| Occupancy-licensed beds (All) | 62.1% | Three Months Ended June 30, 2026 filing | — |
| Patient days (All) | 420,001 | Three Months Ended June 30, 2026 filing | — |
| Patient days (Same Facility Basis) non-GAAP | 419,710 | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
UHS
this stock
Universal Health Services Inc
|
$10.54B | -20.1% | +9.7% | 7.3 | 4.6% |
|
HCA
HCA Healthcare, Inc.
|
$96.64B | -8.6% | +7.1% | 15.0 | 2.9% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$29.92B | -11.6% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$20.91B | +28.6% | +0.9% | 10.0 | 2.5% |
|
EHC
Encompass Health Corp
|
$12.18B | +14.5% | +10.5% | 20.1 | 3.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| UHS | -3.9% | +2.1% | -7.3% | +2.3% | -20.1% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -3.3% | +2.0% | -19.4% | +2.9% | -31.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.